Captrust Financial Advisors Nevro Corp Transaction History

Captrust Financial Advisors

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 16, 2022	BUY	$40.85 - $77.67 $3,758 - $7,145	92 Added 38.49%	331 $15,000
Q1 2022 May 16, 2022	SELL	$59.95 - $92.06 $599 - $920	-10 Reduced 4.02%	239 $17,000
Q4 2021 Feb 14, 2022	BUY	$81.07 - $121.29 $9,485 - $14,190	117 Added 88.64%	249 $20,000
Q3 2021 Nov 16, 2021	SELL	$101.99 - $166.36 $8,771 - $14,306	-86 Reduced 39.45%	132 $15,000
Q2 2021 Aug 16, 2021	BUY	$141.6 - $179.06 $17,983 - $22,740	127 Added 139.56%	218 $36,000
Q1 2021 May 17, 2021	SELL	$132.81 - $182.18 $10,624 - $14,574	-80 Reduced 46.78%	91 $13,000
Q4 2020 Feb 16, 2021	SELL	$138.17 - $184.34 $414 - $553	-3 Reduced 1.72%	171 $30,000
Q3 2020 Nov 17, 2020	BUY	$114.09 - $145.51 $570 - $727	5 Added 2.96%	174 $24,000
Q2 2020 Aug 14, 2020	BUY	$89.45 - $129.85 $15,117 - $21,944	169 New	169 $20,000
Q4 2019 Feb 14, 2020	SELL	$76.41 - $117.54 $3,514 - $5,406	-46 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$61.52 - $91.1 $1,661 - $2,459	-27 Reduced 36.99%	46 $4,000
Q1 2019 May 15, 2019	SELL	$35.52 - $62.62 $1,562 - $2,755	-44 Reduced 37.61%	73 $5,000
Q2 2018 Aug 13, 2018	BUY	$72.38 - $92.5 $7,961 - $10,175	110 Added 1571.43%	117 $9,000
Q1 2018 May 15, 2018	BUY	$69.46 - $88.57 $486 - $619	7 New	7 $1,000

151

39.3M

67.9K

1.59M

Ticker NVRO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,387,800
Market Cap $116M
Description
Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

Stay updated on Captrust Financial Advisors with notifications on news.